Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial.
Stem Cell Res Ther. 2022 Jun 20;13(1):264. doi: 10.1186/s13287-022-02941-w.
Stem Cell Res Ther. 2022.
PMID: 35725652
Free PMC article.
Clinical Trial.
Combined therapy of mesenchymal stem cells with a GLP-1 receptor agonist, liraglutide, on an inflammatory-mediated diabetic non-human primate model.
Navabi R, Negahdari B, Hajizadeh-Saffar E, Hajinasrollah M, Jenab Y, Rabbani S, Pakzad M, Hassani SN, Hezavehei M, Jafari-Atrabi M, Tahamtani Y, Baharvand H.
Navabi R, et al.
Life Sci. 2021 Jul 1;276:119374. doi: 10.1016/j.lfs.2021.119374. Epub 2021 Mar 18.
Life Sci. 2021.
PMID: 33745896
Item in Clipboard
Immunomodulatory potential of human clonal mesenchymal stem cells and their extracellular vesicle subpopulations in an inflammatory-mediated diabetic Rhesus monkey model.
Kashani SA, Navabi R, Amini A, Hajinasrollah M, Jenab Y, Rabbani S, Nazari A, Pakzad M, Moazenchi M, Atrabi MJ, Samsonchi Z, Hezavehei M, Hosseini-Beheshti E, Shekari F, Hajizadeh-Saffar E, Baharvand H.
Kashani SA, et al. Among authors: navabi r.
Life Sci. 2023 Sep 15;329:121950. doi: 10.1016/j.lfs.2023.121950. Epub 2023 Jul 18.
Life Sci. 2023.
PMID: 37473804
Item in Clipboard
Cite
Cite